UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]
Sol-Gel Technologies Ltd. (SLGL)
Last sol-gel technologies ltd. earnings: 11/13 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/markets/ipos/company/solgel-technologies-ltd-1031585-84610
Company Research
Source: Yahoo! Finance
Ongoing Phase 3 clinical trial of SGT-610 for Gorlin Syndrome with over 30 clinical sites activated; Top-line results are expected by the second quarter of 2026 SGT-210 proof-of-concept study in patients suffering from Darier disease, a significant unmet medical need in dermatology, is ongoing Sol-Gel sells its rights in the Abbreviated New Drug Application (ANDA) drug product generic to Zoryve ® Cream (roflumilast cream 0.3%) Following management realignment, Mr. Mori Arkin, the Company's executive chairman and controlling shareholder to be appointed as Company's interim CEO as of January 1, 2025, subject to shareholders approval Sol-Gel recently signed license agreements with respect to TWYNEO and EPSOLAY in Europe and South Africa and is negotiating additional license deals in Latin America and other territories NESS ZIONA, Israel, Aug. 17, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company, pioneering treatments for patients with s
Show less
Read more
Impact Snapshot
Event Time:
SLGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLGL alerts
High impacting Sol-Gel Technologies Ltd. news events
Weekly update
A roundup of the hottest topics
SLGL
News
- All You Need to Know About SolGel Technologies (SLGL) Rating Upgrade to Strong Buy [Yahoo! Finance]Yahoo! Finance
- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) was downgraded by analysts at Raymond James from a "strong-buy" rating to an "outperform" rating. They now have a $4.00 price target on the stock, down previously from $6.00.MarketBeat
- UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesGlobeNewswire
- Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesGlobeNewswire
- Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South AfricaGlobeNewswire
SLGL
Earnings
- 8/16/24 - Beat
SLGL
Sec Filings
- 8/27/24 - Form 6-K
- 8/19/24 - Form 424B3
- 8/19/24 - Form 6-K/A
- SLGL's page on the SEC website